Product progress

PTS Product Development Pipeline - Human Indication

PTS Indication	Pre-clinical phase	Clinical phase I	Clinical phase II	Clinical phase III	NDA Submission	NDA Approval
PTS 302 Severe Malignant Airway Obstruction
PTS 100 Hepatocellular Carcinoma
PTS 500 Malignant pleural effusion
PTS 02 Adenoid cystic carcinoma

PTS Medicinal product for veterinary use	Pre-field trial		Field trial	NDA Submission	NDA Approval	Market Development
GWA 103 Canine melanoma
GWA 106 Anti-tumor drug for Equine use